References
- A Jablensky. The 100-year epidemiology of schizophrenia. Schizophr Res 1997;28:111–125.
- KT Mueser, SR McGurk. Schizophrenia. Lancet 2004;363:2063–2072.
- P Seeman, T Lee. Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 1975;188 (4194):1217–1219.
- I Creese, DR Burt, SH Snyder. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976;192 (4238):481–483.
- S Miyamoto, GE Duncan, CE Marx, JA Lieberman. Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005;10:79–104.
- R Matz, W Rick, D Oh, H Thompson, S Gershon. Clozapine – a potential antipsychotic agent without extrapyramidal manifestations. Psychopharmacol Bull 1975;11 (1):14–19.
- J Horacek, V Bubenikova-Valesova, M Kopecek, T Palenicek, C Dockery, P Mohr, C Hoschl. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 2006;20 (5):389–409.
- CA Tamminga. The promise of new drugs for schizophrenia treatment. Can J Psychiatry 1997;42 (3):265–273.
- DC Goff, JT Coyle. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001;158:1367–1377.
- GE Duncan, S Zorn, JA Lieberman. Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia. Mol Psychiatry 1999;4:418–428.
- PD Leeson, LL Iversen. The glycine site on the NMDA receptor: Structure–activity relationships and therapeutic potential. J Med Chem 1994;37:4053–4067.
- DC Goff, G Tsai, DS Manoach, JT Coyle. Dose-finding trial of D cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 1995;152:1213–1215.
- DC Javitt, I Zylberman, SR Zukin, U Heresco-Levy, JP Lindenmayer. Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994;151:1234–1236.
- SF Brain, JH Antony, WG Peter, PWG Smith, RT Austin. Vogels text book of practical organic chemistry. 5th ed. 1989. p 1155.
- B Costall, RJ Naylor, V Nohria. Climbing behaviour induced by Apomorphine in mice: A potential model for detection of neuroleptic activity. Eur J Pharmacol 1978;50:39–50.
- JB Malick, E Doren, A Barnett. Quipazine induced head twitch in mice. Pharmacol Biochem Behav 1977;6:325–329.